Buscar
-
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
(Neurotherapeutics. vol. 19, n° 2, pp. 476-490, 2022-03)Article de revueLibre acceso -
Metabolic Recruitment in Brain Tissue
(Annual Review of Physiology. vol. 85, pp. 115-135, 2023-02-10)Article de revueLibre acceso -
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome
(Annales d'Endocrinologie. vol. 83, n° 2, pp. 119-141, 2022-04)Article de revue -
Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer’s disease
(European Radiology. vol. 33, n° 1, pp. 194-195, 2022-07-26)Article de revue -
Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
(Science Advances. vol. 8, n° 30, 2022-07-29)Article de revueLibre acceso -
MRI characteristics of MOG-Ab associated disease in adults: an update
(2021)Document de travail - Pré-publicationLibre acceso -
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
(Multiple Sclerosis and Related Disorders. vol. 48, 2021-02)Article de revueLibre acceso -
Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries
(2022)Document de travail - Pré-publicationLibre acceso -
Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder
(Autism Research. vol. 14, n° 9, pp. 1854-1872, 2021-09)Article de revueLibre acceso -
Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
(Frontiers in Molecular Neuroscience. vol. 13, n° 142, 2020-06-12)Article de revueLibre acceso